IBM Elects Michael Miebach to its Board of Directors
ARMONK, N.Y., July 31, 2023 /PRNewswire/ — The IBM (NYSE: IBM) board of directors has elected Michael Miebach to the board, effective October 30, 2023. Michael Miebach, 55, is the …
ARMONK, N.Y., July 31, 2023 /PRNewswire/ — The IBM (NYSE: IBM) board of directors has elected Michael Miebach to the board, effective October 30, 2023. Michael Miebach, 55, is the …
WASHINGTON, July 31, 2023 /PRNewswire/ — Brand USA, the destination marketing organization for the United States, announces the impending retirement of Chris Thompson as President and CEO, effective May 31, …
Key Highlights of Q1FY24 Financial Results (Standalone): Revenue from Operations: Rs. 113.07 Crore, 15.74% YoY growth. Gross Profit: Rs. 56.31 Crore, 14.97% YoY growth. EBIDTA as a % of Revenue: …
LOS ANGELES, July 31, 2023 /PRNewswire/ — Today, Zefr’s third-party brand suitability verification solution for Instagram Feed is now available. This AI-powered measurement solution provides marketers with even more transparency …
WASHINGTON, July 31, 2023 /PRNewswire/ — EARTHDAY.ORG, the global organizer of Earth Day, has announced the global theme for Earth Day 2024: Planet vs. Plastics. Planet vs. Plastics unites students, parents, …
MUMBAI, India , July 31, 2023 /PRNewswire/ — Liberty General Insurance, one of the leading non-life insurance companies in India, has been appointed as the “Lead Insurer” for Delhi by the …
SHANGHAI, July 31, 2023 /PRNewswire/ — The 2023 China Digital Entertainment Congress commenced on Thursday alongside ChinaJoy, the country’s largest gaming event. Lu Xiaoyin, Co-CEO and President of Perfect World Co., …
– Plans to add more than 50,000 life advisors and open around 100 new offices across locations in the country NEW DELHI, July 31, 2023 /PRNewswire/ — Max Life Insurance …
With TCL’s latest intelligent algorithm, the enhanced picture quality elevates the experience of movie watching, game play and more HONG KONG, July 31, 2023 /PRNewswire/ — TCL, a leading consumer electronics …
– Daewoong Pharmaceutical, “Expecting the smooth approval with the successful phase 3 clinical trial in China aiming to reach 100 countries by 2027″ SEOUL, South Korea, July 31, 2023 /PRNewswire/ …